Language selection

Search

Details for: ZONOVATE

Company: NOVO NORDISK CANADA INC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02435187ZONOVATETUROCTOCOG ALFA250 UNIT / VIALPOWDER FOR SOLUTIONINTRAVENOUS
02435187ZONOVATETUROCTOCOG ALFA250 UNIT / VIALKITINTRAVENOUS
02435195ZONOVATETUROCTOCOG ALFA500 UNIT / VIALPOWDER FOR SOLUTIONINTRAVENOUS
02435195ZONOVATETUROCTOCOG ALFA500 UNIT / VIALKITINTRAVENOUS
02435209ZONOVATETUROCTOCOG ALFA1000 UNIT / VIALPOWDER FOR SOLUTIONINTRAVENOUS
02435209ZONOVATETUROCTOCOG ALFA1000 UNIT / VIALKITINTRAVENOUS
02435217ZONOVATETUROCTOCOG ALFA1500 UNIT / VIALPOWDER FOR SOLUTIONINTRAVENOUS
02435217ZONOVATETUROCTOCOG ALFA1500 UNIT / VIALKITINTRAVENOUS
02435225ZONOVATETUROCTOCOG ALFA2000 UNIT / VIALPOWDER FOR SOLUTIONINTRAVENOUS
02435225ZONOVATETUROCTOCOG ALFA2000 UNIT / VIALKITINTRAVENOUS
02435233ZONOVATETUROCTOCOG ALFA3000 UNIT / VIALPOWDER FOR SOLUTIONINTRAVENOUS
02435233ZONOVATETUROCTOCOG ALFA3000 UNIT / VIALKITINTRAVENOUS
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Basis of Decision
Regulatory Decision Summary

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: